database,exposure,outcomeCategory,Disease,denomPatid,denomIndexExp,timeWindow,numer,prevPct
MPCD,DMARD,Cancer,Hematologic Cancer,421,481,12 months,1,0.2079002079
MPCD,DMARD,Cancer,Hematologic Cancer,421,481,24 months,2,0.4158004158
MPCD,DMARD,Cancer,Hematologic Cancer,421,481,36 months,3,0.6237006237
MPCD,DMARD,Cancer,Hematologic Cancer,421,481,AS cohort entry to exposure,1,0.2079002079
MPCD,DMARD,Cancer,Solid Cancer,421,481,12 months,7,1.4553014553
MPCD,DMARD,Cancer,Solid Cancer,421,481,24 months,11,2.2869022869
MPCD,DMARD,Cancer,Solid Cancer,421,481,36 months,11,2.2869022869
MPCD,DMARD,Cancer,Solid Cancer,421,481,AS cohort entry to exposure,6,1.2474012474
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,421,481,12 months,5,1.0395010395
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,421,481,24 months,6,1.2474012474
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,421,481,36 months,7,1.4553014553
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,421,481,AS cohort entry to exposure,2,0.4158004158
MPCD,DMARD,Infection,Opportunistic infection,421,481,12 months,5,1.0395010395
MPCD,DMARD,Infection,Opportunistic infection,421,481,24 months,9,1.8711018711
MPCD,DMARD,Infection,Opportunistic infection,421,481,36 months,11,2.2869022869
MPCD,DMARD,Infection,Opportunistic infection,421,481,AS cohort entry to exposure,4,0.8316008316
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,421,481,12 months,18,3.7422037422
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,421,481,24 months,20,4.158004158
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,421,481,36 months,20,4.158004158
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,421,481,AS cohort entry to exposure,14,2.9106029106
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,421,481,12 months,12,2.4948024948
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,421,481,24 months,13,2.7027027027
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,421,481,36 months,13,2.7027027027
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,421,481,AS cohort entry to exposure,7,1.4553014553
MPCD,DMARD,Kidney disease,IgA nephropathy,421,481,12 months,1,0.2079002079
MPCD,DMARD,Kidney disease,IgA nephropathy,421,481,24 months,1,0.2079002079
MPCD,DMARD,Kidney disease,IgA nephropathy,421,481,36 months,1,0.2079002079
MPCD,DMARD,Kidney disease,IgA nephropathy,421,481,AS cohort entry to exposure,1,0.2079002079
MPCD,DMARD,Lung disease,Restrictive lung disease ,421,481,12 months,2,0.4158004158
MPCD,DMARD,Lung disease,Restrictive lung disease ,421,481,24 months,3,0.6237006237
MPCD,DMARD,Lung disease,Restrictive lung disease ,421,481,36 months,4,0.8316008316
MPCD,DMARD,Lung disease,Restrictive lung disease ,421,481,AS cohort entry to exposure,2,0.4158004158
MPCD,DMARD,PsO/PsA,Psoriasis,421,481,12 months,6,1.2474012474
MPCD,DMARD,PsO/PsA,Psoriasis,421,481,24 months,10,2.079002079
MPCD,DMARD,PsO/PsA,Psoriasis,421,481,36 months,13,2.7027027027
MPCD,DMARD,PsO/PsA,Psoriasis,421,481,AS cohort entry to exposure,6,1.2474012474
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,421,481,12 months,26,5.4054054054
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,421,481,24 months,30,6.237006237
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,421,481,36 months,31,6.4449064449
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,421,481,AS cohort entry to exposure,21,4.3659043659
MPCD,DMARD,Uveitis,Uveitis,421,481,12 months,28,5.8212058212
MPCD,DMARD,Uveitis,Uveitis,421,481,24 months,33,6.8607068607
MPCD,DMARD,Uveitis,Uveitis,421,481,36 months,35,7.2765072765
MPCD,DMARD,Uveitis,Uveitis,421,481,AS cohort entry to exposure,22,4.5738045738
MPCD,NSAID or no exposure,Cancer,Hematologic Cancer,2083,2593,12 months,10,0.385653683
MPCD,NSAID or no exposure,Cancer,Hematologic Cancer,2083,2593,24 months,14,0.5399151562
MPCD,NSAID or no exposure,Cancer,Hematologic Cancer,2083,2593,36 months,14,0.5399151562
MPCD,NSAID or no exposure,Cancer,Hematologic Cancer,2083,2593,AS cohort entry to exposure,1,0.0385653683
MPCD,NSAID or no exposure,Cancer,Solid Cancer,2083,2593,12 months,90,3.4708831469
MPCD,NSAID or no exposure,Cancer,Solid Cancer,2083,2593,24 months,124,4.7821056691
MPCD,NSAID or no exposure,Cancer,Solid Cancer,2083,2593,36 months,136,5.2448900887
MPCD,NSAID or no exposure,Cancer,Solid Cancer,2083,2593,AS cohort entry to exposure,27,1.0412649441
MPCD,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2083,2593,12 months,40,1.542614732
MPCD,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2083,2593,24 months,54,2.0825298882
MPCD,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2083,2593,36 months,59,2.2753567297
MPCD,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2083,2593,AS cohort entry to exposure,4,0.1542614732
MPCD,NSAID or no exposure,Cardiac disease,Conduction Block,2083,2593,12 months,17,0.6556112611
MPCD,NSAID or no exposure,Cardiac disease,Conduction Block,2083,2593,24 months,23,0.8870034709
MPCD,NSAID or no exposure,Cardiac disease,Conduction Block,2083,2593,36 months,28,1.0798303124
MPCD,NSAID or no exposure,Cardiac disease,Conduction Block,2083,2593,AS cohort entry to exposure,2,0.0771307366
MPCD,NSAID or no exposure,Cardiac disease,Myocardial infarction,2083,2593,12 months,1,0.0385653683
MPCD,NSAID or no exposure,Cardiac disease,Myocardial infarction,2083,2593,24 months,1,0.0385653683
MPCD,NSAID or no exposure,Cardiac disease,Myocardial infarction,2083,2593,36 months,1,0.0385653683
MPCD,NSAID or no exposure,Cardiac disease,Myocardial infarction,2083,2593,AS cohort entry to exposure,0,0
MPCD,NSAID or no exposure,Infection,Hospitalized infection,2083,2593,12 months,5,0.1928268415
MPCD,NSAID or no exposure,Infection,Hospitalized infection,2083,2593,24 months,6,0.2313922098
MPCD,NSAID or no exposure,Infection,Hospitalized infection,2083,2593,36 months,6,0.2313922098
MPCD,NSAID or no exposure,Infection,Hospitalized infection,2083,2593,AS cohort entry to exposure,4,0.1542614732
MPCD,NSAID or no exposure,Infection,Opportunistic infection,2083,2593,12 months,21,0.8098727343
MPCD,NSAID or no exposure,Infection,Opportunistic infection,2083,2593,24 months,24,0.9255688392
MPCD,NSAID or no exposure,Infection,Opportunistic infection,2083,2593,36 months,27,1.0412649441
MPCD,NSAID or no exposure,Infection,Opportunistic infection,2083,2593,AS cohort entry to exposure,7,0.2699575781
MPCD,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,2083,2593,12 months,81,3.1237948322
MPCD,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,2083,2593,24 months,93,3.5865792518
MPCD,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,2083,2593,36 months,100,3.8565368299
MPCD,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,2083,2593,AS cohort entry to exposure,28,1.0798303124
MPCD,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,2083,2593,12 months,42,1.6197454686
MPCD,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,2083,2593,24 months,50,1.928268415
MPCD,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,2083,2593,36 months,51,1.9668337833
MPCD,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,2083,2593,AS cohort entry to exposure,22,0.8484381026
MPCD,NSAID or no exposure,Kidney disease,Amyloidosis,2083,2593,12 months,1,0.0385653683
MPCD,NSAID or no exposure,Kidney disease,Amyloidosis,2083,2593,24 months,1,0.0385653683
MPCD,NSAID or no exposure,Kidney disease,Amyloidosis,2083,2593,36 months,1,0.0385653683
MPCD,NSAID or no exposure,Kidney disease,Amyloidosis,2083,2593,AS cohort entry to exposure,0,0
MPCD,NSAID or no exposure,Kidney disease,IgA nephropathy,2083,2593,12 months,3,0.1156961049
MPCD,NSAID or no exposure,Kidney disease,IgA nephropathy,2083,2593,24 months,6,0.2313922098
MPCD,NSAID or no exposure,Kidney disease,IgA nephropathy,2083,2593,36 months,8,0.3085229464
MPCD,NSAID or no exposure,Kidney disease,IgA nephropathy,2083,2593,AS cohort entry to exposure,2,0.0771307366
MPCD,NSAID or no exposure,Lung disease,Restrictive lung disease ,2083,2593,12 months,31,1.1955264173
MPCD,NSAID or no exposure,Lung disease,Restrictive lung disease ,2083,2593,24 months,53,2.0439645199
MPCD,NSAID or no exposure,Lung disease,Restrictive lung disease ,2083,2593,36 months,59,2.2753567297
MPCD,NSAID or no exposure,Lung disease,Restrictive lung disease ,2083,2593,AS cohort entry to exposure,12,0.4627844196
MPCD,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,2083,2593,12 months,2,0.0771307366
MPCD,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,2083,2593,24 months,3,0.1156961049
MPCD,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,2083,2593,36 months,3,0.1156961049
MPCD,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,2083,2593,AS cohort entry to exposure,1,0.0385653683
MPCD,NSAID or no exposure,Neurological Disease,Spinal Cord compression,2083,2593,12 months,9,0.3470883147
MPCD,NSAID or no exposure,Neurological Disease,Spinal Cord compression,2083,2593,24 months,11,0.4242190513
MPCD,NSAID or no exposure,Neurological Disease,Spinal Cord compression,2083,2593,36 months,13,0.5013497879
MPCD,NSAID or no exposure,Neurological Disease,Spinal Cord compression,2083,2593,AS cohort entry to exposure,4,0.1542614732
MPCD,NSAID or no exposure,PsO/PsA,Psoriasis,2083,2593,12 months,47,1.8125723101
MPCD,NSAID or no exposure,PsO/PsA,Psoriasis,2083,2593,24 months,65,2.5067489395
MPCD,NSAID or no exposure,PsO/PsA,Psoriasis,2083,2593,36 months,70,2.6995757809
MPCD,NSAID or no exposure,PsO/PsA,Psoriasis,2083,2593,AS cohort entry to exposure,23,0.8870034709
MPCD,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,2083,2593,12 months,58,2.2367913614
MPCD,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,2083,2593,24 months,70,2.6995757809
MPCD,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,2083,2593,36 months,79,3.0466640956
MPCD,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,2083,2593,AS cohort entry to exposure,28,1.0798303124
MPCD,NSAID or no exposure,Uveitis,Uveitis,2083,2593,12 months,134,5.1677593521
MPCD,NSAID or no exposure,Uveitis,Uveitis,2083,2593,24 months,156,6.0161974547
MPCD,NSAID or no exposure,Uveitis,Uveitis,2083,2593,36 months,167,6.440416506
MPCD,NSAID or no exposure,Uveitis,Uveitis,2083,2593,AS cohort entry to exposure,63,2.4296182029
MPCD,TNF,Cancer,Hematologic Cancer,1107,1279,12 months,4,0.3127443315
MPCD,TNF,Cancer,Hematologic Cancer,1107,1279,24 months,5,0.3909304144
MPCD,TNF,Cancer,Hematologic Cancer,1107,1279,36 months,5,0.3909304144
MPCD,TNF,Cancer,Hematologic Cancer,1107,1279,AS cohort entry to exposure,5,0.3909304144
MPCD,TNF,Cancer,Solid Cancer,1107,1279,12 months,27,2.1110242377
MPCD,TNF,Cancer,Solid Cancer,1107,1279,24 months,31,2.4237685692
MPCD,TNF,Cancer,Solid Cancer,1107,1279,36 months,34,2.6583268178
MPCD,TNF,Cancer,Solid Cancer,1107,1279,AS cohort entry to exposure,16,1.250977326
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1107,1279,12 months,23,1.7982799062
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1107,1279,24 months,29,2.2673964034
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1107,1279,36 months,30,2.3455824863
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1107,1279,AS cohort entry to exposure,18,1.4073494918
MPCD,TNF,Cardiac disease,Conduction Block,1107,1279,12 months,3,0.2345582486
MPCD,TNF,Cardiac disease,Conduction Block,1107,1279,24 months,5,0.3909304144
MPCD,TNF,Cardiac disease,Conduction Block,1107,1279,36 months,5,0.3909304144
MPCD,TNF,Cardiac disease,Conduction Block,1107,1279,AS cohort entry to exposure,2,0.1563721658
MPCD,TNF,Infection,Hospitalized infection,1107,1279,12 months,1,0.0781860829
MPCD,TNF,Infection,Hospitalized infection,1107,1279,24 months,2,0.1563721658
MPCD,TNF,Infection,Hospitalized infection,1107,1279,36 months,2,0.1563721658
MPCD,TNF,Infection,Hospitalized infection,1107,1279,AS cohort entry to exposure,2,0.1563721658
MPCD,TNF,Infection,Opportunistic infection,1107,1279,12 months,17,1.3291634089
MPCD,TNF,Infection,Opportunistic infection,1107,1279,24 months,22,1.7200938233
MPCD,TNF,Infection,Opportunistic infection,1107,1279,36 months,23,1.7982799062
MPCD,TNF,Infection,Opportunistic infection,1107,1279,AS cohort entry to exposure,11,0.8600469116
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,1107,1279,12 months,74,5.7857701329
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,1107,1279,24 months,81,6.3330727131
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,1107,1279,36 months,84,6.5676309617
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,1107,1279,AS cohort entry to exposure,66,5.1602814699
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,1107,1279,12 months,37,2.8928850665
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,1107,1279,24 months,44,3.4401876466
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,1107,1279,36 months,48,3.7529319781
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,1107,1279,AS cohort entry to exposure,27,2.1110242377
MPCD,TNF,Kidney disease,IgA nephropathy,1107,1279,12 months,4,0.3127443315
MPCD,TNF,Kidney disease,IgA nephropathy,1107,1279,24 months,4,0.3127443315
MPCD,TNF,Kidney disease,IgA nephropathy,1107,1279,36 months,4,0.3127443315
MPCD,TNF,Kidney disease,IgA nephropathy,1107,1279,AS cohort entry to exposure,1,0.0781860829
MPCD,TNF,Lung disease,Restrictive lung disease ,1107,1279,12 months,9,0.7036747459
MPCD,TNF,Lung disease,Restrictive lung disease ,1107,1279,24 months,15,1.1727912432
MPCD,TNF,Lung disease,Restrictive lung disease ,1107,1279,36 months,17,1.3291634089
MPCD,TNF,Lung disease,Restrictive lung disease ,1107,1279,AS cohort entry to exposure,10,0.7818608288
MPCD,TNF,Neurological Disease,Spinal Cord compression,1107,1279,12 months,2,0.1563721658
MPCD,TNF,Neurological Disease,Spinal Cord compression,1107,1279,24 months,2,0.1563721658
MPCD,TNF,Neurological Disease,Spinal Cord compression,1107,1279,36 months,2,0.1563721658
MPCD,TNF,Neurological Disease,Spinal Cord compression,1107,1279,AS cohort entry to exposure,0,0
MPCD,TNF,PsO/PsA,Psoriasis,1107,1279,12 months,53,4.1438623925
MPCD,TNF,PsO/PsA,Psoriasis,1107,1279,24 months,66,5.1602814699
MPCD,TNF,PsO/PsA,Psoriasis,1107,1279,36 months,71,5.5512118843
MPCD,TNF,PsO/PsA,Psoriasis,1107,1279,AS cohort entry to exposure,37,2.8928850665
MPCD,TNF,PsO/PsA,Psoriatic arthritis,1107,1279,12 months,82,6.4112587959
MPCD,TNF,PsO/PsA,Psoriatic arthritis,1107,1279,24 months,97,7.5840500391
MPCD,TNF,PsO/PsA,Psoriatic arthritis,1107,1279,36 months,102,7.9749804535
MPCD,TNF,PsO/PsA,Psoriatic arthritis,1107,1279,AS cohort entry to exposure,69,5.3948397185
MPCD,TNF,Uveitis,Uveitis,1107,1279,12 months,92,7.1931196247
MPCD,TNF,Uveitis,Uveitis,1107,1279,24 months,104,8.1313526192
MPCD,TNF,Uveitis,Uveitis,1107,1279,36 months,110,8.6004691165
MPCD,TNF,Uveitis,Uveitis,1107,1279,AS cohort entry to exposure,77,6.0203283815
Marketscan,DMARD,Cancer,Hematologic Cancer,1799,2045,12 months,12,0.586797066
Marketscan,DMARD,Cancer,Hematologic Cancer,1799,2045,24 months,17,0.8312958435
Marketscan,DMARD,Cancer,Hematologic Cancer,1799,2045,36 months,18,0.880195599
Marketscan,DMARD,Cancer,Hematologic Cancer,1799,2045,AS cohort entry to exposure,8,0.391198044
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,1799,2045,12 months,3,0.1466992665
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,1799,2045,24 months,6,0.293398533
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,1799,2045,36 months,9,0.4400977995
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,1799,2045,AS cohort entry to exposure,3,0.1466992665
Marketscan,DMARD,Cancer,Solid Cancer,1799,2045,12 months,59,2.8850855746
Marketscan,DMARD,Cancer,Solid Cancer,1799,2045,24 months,68,3.3251833741
Marketscan,DMARD,Cancer,Solid Cancer,1799,2045,36 months,78,3.8141809291
Marketscan,DMARD,Cancer,Solid Cancer,1799,2045,AS cohort entry to exposure,46,2.2493887531
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1799,2045,12 months,13,0.6356968215
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1799,2045,24 months,16,0.782396088
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1799,2045,36 months,19,0.9290953545
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1799,2045,AS cohort entry to exposure,6,0.293398533
Marketscan,DMARD,Cardiac disease,Conduction Block,1799,2045,12 months,19,0.9290953545
Marketscan,DMARD,Cardiac disease,Conduction Block,1799,2045,24 months,22,1.075794621
Marketscan,DMARD,Cardiac disease,Conduction Block,1799,2045,36 months,23,1.1246943765
Marketscan,DMARD,Cardiac disease,Conduction Block,1799,2045,AS cohort entry to exposure,11,0.5378973105
Marketscan,DMARD,Cardiac disease,Myocardial infarction,1799,2045,12 months,2,0.097799511
Marketscan,DMARD,Cardiac disease,Myocardial infarction,1799,2045,24 months,5,0.2444987775
Marketscan,DMARD,Cardiac disease,Myocardial infarction,1799,2045,36 months,6,0.293398533
Marketscan,DMARD,Cardiac disease,Myocardial infarction,1799,2045,AS cohort entry to exposure,5,0.2444987775
Marketscan,DMARD,Infection,Hospitalized infection,1799,2045,12 months,71,3.4718826406
Marketscan,DMARD,Infection,Hospitalized infection,1799,2045,24 months,107,5.2322738386
Marketscan,DMARD,Infection,Hospitalized infection,1799,2045,36 months,116,5.6723716381
Marketscan,DMARD,Infection,Hospitalized infection,1799,2045,AS cohort entry to exposure,68,3.3251833741
Marketscan,DMARD,Infection,Opportunistic infection,1799,2045,12 months,16,0.782396088
Marketscan,DMARD,Infection,Opportunistic infection,1799,2045,24 months,20,0.97799511
Marketscan,DMARD,Infection,Opportunistic infection,1799,2045,36 months,20,0.97799511
Marketscan,DMARD,Infection,Opportunistic infection,1799,2045,AS cohort entry to exposure,7,0.3422982885
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,1799,2045,12 months,55,2.6894865526
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,1799,2045,24 months,63,3.0806845966
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,1799,2045,36 months,67,3.2762836186
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,1799,2045,AS cohort entry to exposure,47,2.2982885086
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1799,2045,12 months,31,1.5158924205
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1799,2045,24 months,37,1.8092909535
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1799,2045,36 months,40,1.95599022
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1799,2045,AS cohort entry to exposure,16,0.782396088
Marketscan,DMARD,Kidney disease,IgA nephropathy,1799,2045,12 months,2,0.097799511
Marketscan,DMARD,Kidney disease,IgA nephropathy,1799,2045,24 months,2,0.097799511
Marketscan,DMARD,Kidney disease,IgA nephropathy,1799,2045,36 months,2,0.097799511
Marketscan,DMARD,Kidney disease,IgA nephropathy,1799,2045,AS cohort entry to exposure,1,0.0488997555
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,1799,2045,12 months,0,0
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,1799,2045,24 months,0,0
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,1799,2045,36 months,2,0.097799511
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,1799,2045,AS cohort entry to exposure,0,0
Marketscan,DMARD,Lung disease,Interstitial lung disease,1799,2045,12 months,1,0.0488997555
Marketscan,DMARD,Lung disease,Interstitial lung disease,1799,2045,24 months,2,0.097799511
Marketscan,DMARD,Lung disease,Interstitial lung disease,1799,2045,36 months,2,0.097799511
Marketscan,DMARD,Lung disease,Interstitial lung disease,1799,2045,AS cohort entry to exposure,1,0.0488997555
Marketscan,DMARD,Lung disease,Restrictive lung disease ,1799,2045,12 months,17,0.8312958435
Marketscan,DMARD,Lung disease,Restrictive lung disease ,1799,2045,24 months,22,1.075794621
Marketscan,DMARD,Lung disease,Restrictive lung disease ,1799,2045,36 months,25,1.2224938875
Marketscan,DMARD,Lung disease,Restrictive lung disease ,1799,2045,AS cohort entry to exposure,18,0.880195599
Marketscan,DMARD,Neurological Disease,Cauda Equina syndrome,1799,2045,12 months,2,0.097799511
Marketscan,DMARD,Neurological Disease,Cauda Equina syndrome,1799,2045,24 months,2,0.097799511
Marketscan,DMARD,Neurological Disease,Cauda Equina syndrome,1799,2045,36 months,2,0.097799511
Marketscan,DMARD,Neurological Disease,Cauda Equina syndrome,1799,2045,AS cohort entry to exposure,1,0.0488997555
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,1799,2045,12 months,5,0.2444987775
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,1799,2045,24 months,7,0.3422982885
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,1799,2045,36 months,8,0.391198044
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,1799,2045,AS cohort entry to exposure,1,0.0488997555
Marketscan,DMARD,PsO/PsA,Psoriasis,1799,2045,12 months,18,0.880195599
Marketscan,DMARD,PsO/PsA,Psoriasis,1799,2045,24 months,23,1.1246943765
Marketscan,DMARD,PsO/PsA,Psoriasis,1799,2045,36 months,25,1.2224938875
Marketscan,DMARD,PsO/PsA,Psoriasis,1799,2045,AS cohort entry to exposure,9,0.4400977995
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,1799,2045,12 months,43,2.1026894866
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,1799,2045,24 months,59,2.8850855746
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,1799,2045,36 months,61,2.9828850856
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,1799,2045,AS cohort entry to exposure,21,1.0268948655
Marketscan,DMARD,Uveitis,Uveitis,1799,2045,12 months,31,1.5158924205
Marketscan,DMARD,Uveitis,Uveitis,1799,2045,24 months,38,1.858190709
Marketscan,DMARD,Uveitis,Uveitis,1799,2045,36 months,42,2.0537897311
Marketscan,DMARD,Uveitis,Uveitis,1799,2045,AS cohort entry to exposure,19,0.9290953545
Marketscan,NSAID or no exposure,Cancer,Hematologic Cancer,8025,10589,12 months,49,0.4627443574
Marketscan,NSAID or no exposure,Cancer,Hematologic Cancer,8025,10589,24 months,63,0.5949570309
Marketscan,NSAID or no exposure,Cancer,Hematologic Cancer,8025,10589,36 months,70,0.6610633676
Marketscan,NSAID or no exposure,Cancer,Hematologic Cancer,8025,10589,AS cohort entry to exposure,29,0.2738691095
Marketscan,NSAID or no exposure,Cancer,Non Melanoma Skin Cancer,8025,10589,12 months,21,0.1983190103
Marketscan,NSAID or no exposure,Cancer,Non Melanoma Skin Cancer,8025,10589,24 months,41,0.3871942582
Marketscan,NSAID or no exposure,Cancer,Non Melanoma Skin Cancer,8025,10589,36 months,48,0.453300595
Marketscan,NSAID or no exposure,Cancer,Non Melanoma Skin Cancer,8025,10589,AS cohort entry to exposure,6,0.0566625744
Marketscan,NSAID or no exposure,Cancer,Solid Cancer,8025,10589,12 months,267,2.5214845594
Marketscan,NSAID or no exposure,Cancer,Solid Cancer,8025,10589,24 months,340,3.2108792143
Marketscan,NSAID or no exposure,Cancer,Solid Cancer,8025,10589,36 months,381,3.5980734725
Marketscan,NSAID or no exposure,Cancer,Solid Cancer,8025,10589,AS cohort entry to exposure,127,1.1993578242
Marketscan,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,8025,10589,12 months,77,0.7271697044
Marketscan,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,8025,10589,24 months,110,1.0388138634
Marketscan,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,8025,10589,36 months,130,1.2276891113
Marketscan,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,8025,10589,AS cohort entry to exposure,37,0.3494192086
Marketscan,NSAID or no exposure,Cardiac disease,Conduction Block,8025,10589,12 months,93,0.8782699027
Marketscan,NSAID or no exposure,Cardiac disease,Conduction Block,8025,10589,24 months,128,1.2088015866
Marketscan,NSAID or no exposure,Cardiac disease,Conduction Block,8025,10589,36 months,145,1.3693455473
Marketscan,NSAID or no exposure,Cardiac disease,Conduction Block,8025,10589,AS cohort entry to exposure,49,0.4627443574
Marketscan,NSAID or no exposure,Cardiac disease,Myocardial infarction,8025,10589,12 months,61,0.5760695061
Marketscan,NSAID or no exposure,Cardiac disease,Myocardial infarction,8025,10589,24 months,75,0.7082821796
Marketscan,NSAID or no exposure,Cardiac disease,Myocardial infarction,8025,10589,36 months,85,0.8027198036
Marketscan,NSAID or no exposure,Cardiac disease,Myocardial infarction,8025,10589,AS cohort entry to exposure,37,0.3494192086
Marketscan,NSAID or no exposure,Infection,Hospitalized infection,8025,10589,12 months,593,5.6001511002
Marketscan,NSAID or no exposure,Infection,Hospitalized infection,8025,10589,24 months,755,7.1300406082
Marketscan,NSAID or no exposure,Infection,Hospitalized infection,8025,10589,36 months,823,7.772216451
Marketscan,NSAID or no exposure,Infection,Hospitalized infection,8025,10589,AS cohort entry to exposure,368,3.4753045613
Marketscan,NSAID or no exposure,Infection,Opportunistic infection,8025,10589,12 months,58,0.5477382189
Marketscan,NSAID or no exposure,Infection,Opportunistic infection,8025,10589,24 months,76,0.717725942
Marketscan,NSAID or no exposure,Infection,Opportunistic infection,8025,10589,36 months,85,0.8027198036
Marketscan,NSAID or no exposure,Infection,Opportunistic infection,8025,10589,AS cohort entry to exposure,27,0.2549815847
Marketscan,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,8025,10589,12 months,202,1.9076400038
Marketscan,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,8025,10589,24 months,244,2.3042780244
Marketscan,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,8025,10589,36 months,262,2.4742657475
Marketscan,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,8025,10589,AS cohort entry to exposure,104,0.9821512891
Marketscan,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,8025,10589,12 months,118,1.1143639626
Marketscan,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,8025,10589,24 months,141,1.3315704977
Marketscan,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,8025,10589,36 months,150,1.4165643592
Marketscan,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,8025,10589,AS cohort entry to exposure,46,0.4344130702
Marketscan,NSAID or no exposure,Kidney disease,Amyloidosis,8025,10589,12 months,1,0.0094437624
Marketscan,NSAID or no exposure,Kidney disease,Amyloidosis,8025,10589,24 months,1,0.0094437624
Marketscan,NSAID or no exposure,Kidney disease,Amyloidosis,8025,10589,36 months,1,0.0094437624
Marketscan,NSAID or no exposure,Kidney disease,Amyloidosis,8025,10589,AS cohort entry to exposure,0,0
Marketscan,NSAID or no exposure,Kidney disease,IgA nephropathy,8025,10589,12 months,2,0.0188875248
Marketscan,NSAID or no exposure,Kidney disease,IgA nephropathy,8025,10589,24 months,2,0.0188875248
Marketscan,NSAID or no exposure,Kidney disease,IgA nephropathy,8025,10589,36 months,2,0.0188875248
Marketscan,NSAID or no exposure,Kidney disease,IgA nephropathy,8025,10589,AS cohort entry to exposure,1,0.0094437624
Marketscan,NSAID or no exposure,Kidney disease,Nephrotic syndrome,8025,10589,12 months,2,0.0188875248
Marketscan,NSAID or no exposure,Kidney disease,Nephrotic syndrome,8025,10589,24 months,4,0.0377750496
Marketscan,NSAID or no exposure,Kidney disease,Nephrotic syndrome,8025,10589,36 months,4,0.0377750496
Marketscan,NSAID or no exposure,Kidney disease,Nephrotic syndrome,8025,10589,AS cohort entry to exposure,0,0
Marketscan,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,8025,10589,12 months,1,0.0094437624
Marketscan,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,8025,10589,24 months,1,0.0094437624
Marketscan,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,8025,10589,36 months,1,0.0094437624
Marketscan,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,8025,10589,AS cohort entry to exposure,0,0
Marketscan,NSAID or no exposure,Lung disease,Interstitial lung disease,8025,10589,12 months,6,0.0566625744
Marketscan,NSAID or no exposure,Lung disease,Interstitial lung disease,8025,10589,24 months,7,0.0661063368
Marketscan,NSAID or no exposure,Lung disease,Interstitial lung disease,8025,10589,36 months,7,0.0661063368
Marketscan,NSAID or no exposure,Lung disease,Interstitial lung disease,8025,10589,AS cohort entry to exposure,4,0.0377750496
Marketscan,NSAID or no exposure,Lung disease,Restrictive lung disease ,8025,10589,12 months,110,1.0388138634
Marketscan,NSAID or no exposure,Lung disease,Restrictive lung disease ,8025,10589,24 months,143,1.3504580225
Marketscan,NSAID or no exposure,Lung disease,Restrictive lung disease ,8025,10589,36 months,159,1.5015582208
Marketscan,NSAID or no exposure,Lung disease,Restrictive lung disease ,8025,10589,AS cohort entry to exposure,40,0.3777504958
Marketscan,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,8025,10589,12 months,3,0.0283312872
Marketscan,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,8025,10589,24 months,3,0.0283312872
Marketscan,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,8025,10589,36 months,3,0.0283312872
Marketscan,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,8025,10589,AS cohort entry to exposure,0,0
Marketscan,NSAID or no exposure,Neurological Disease,Spinal Cord compression,8025,10589,12 months,23,0.2172065351
Marketscan,NSAID or no exposure,Neurological Disease,Spinal Cord compression,8025,10589,24 months,29,0.2738691095
Marketscan,NSAID or no exposure,Neurological Disease,Spinal Cord compression,8025,10589,36 months,31,0.2927566342
Marketscan,NSAID or no exposure,Neurological Disease,Spinal Cord compression,8025,10589,AS cohort entry to exposure,5,0.047218812
Marketscan,NSAID or no exposure,PsO/PsA,Psoriasis,8025,10589,12 months,53,0.5005194069
Marketscan,NSAID or no exposure,PsO/PsA,Psoriasis,8025,10589,24 months,60,0.5666257437
Marketscan,NSAID or no exposure,PsO/PsA,Psoriasis,8025,10589,36 months,71,0.67050713
Marketscan,NSAID or no exposure,PsO/PsA,Psoriasis,8025,10589,AS cohort entry to exposure,20,0.1888752479
Marketscan,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,8025,10589,12 months,65,0.6138445557
Marketscan,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,8025,10589,24 months,82,0.7743885164
Marketscan,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,8025,10589,36 months,92,0.8688261403
Marketscan,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,8025,10589,AS cohort entry to exposure,40,0.3777504958
Marketscan,NSAID or no exposure,Uveitis,Uveitis,8025,10589,12 months,167,1.57710832
Marketscan,NSAID or no exposure,Uveitis,Uveitis,8025,10589,24 months,201,1.8981962414
Marketscan,NSAID or no exposure,Uveitis,Uveitis,8025,10589,36 months,220,2.0776277269
Marketscan,NSAID or no exposure,Uveitis,Uveitis,8025,10589,AS cohort entry to exposure,47,0.4438568326
Marketscan,TNF,Cancer,Hematologic Cancer,4797,5779,12 months,9,0.1557362866
Marketscan,TNF,Cancer,Hematologic Cancer,4797,5779,24 months,18,0.3114725731
Marketscan,TNF,Cancer,Hematologic Cancer,4797,5779,36 months,18,0.3114725731
Marketscan,TNF,Cancer,Hematologic Cancer,4797,5779,AS cohort entry to exposure,4,0.0692161274
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,4797,5779,12 months,12,0.2076483821
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,4797,5779,24 months,21,0.3633846686
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,4797,5779,36 months,25,0.432600796
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,4797,5779,AS cohort entry to exposure,5,0.0865201592
Marketscan,TNF,Cancer,Solid Cancer,4797,5779,12 months,44,0.7613774009
Marketscan,TNF,Cancer,Solid Cancer,4797,5779,24 months,76,1.3151064198
Marketscan,TNF,Cancer,Solid Cancer,4797,5779,36 months,84,1.4535386745
Marketscan,TNF,Cancer,Solid Cancer,4797,5779,AS cohort entry to exposure,41,0.7094653054
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4797,5779,12 months,30,0.5191209552
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4797,5779,24 months,45,0.7786814328
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4797,5779,36 months,55,0.9517217512
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4797,5779,AS cohort entry to exposure,20,0.3460806368
Marketscan,TNF,Cardiac disease,Conduction Block,4797,5779,12 months,29,0.5018169233
Marketscan,TNF,Cardiac disease,Conduction Block,4797,5779,24 months,43,0.7440733691
Marketscan,TNF,Cardiac disease,Conduction Block,4797,5779,36 months,52,0.8998096556
Marketscan,TNF,Cardiac disease,Conduction Block,4797,5779,AS cohort entry to exposure,21,0.3633846686
Marketscan,TNF,Cardiac disease,Myocardial infarction,4797,5779,12 months,9,0.1557362866
Marketscan,TNF,Cardiac disease,Myocardial infarction,4797,5779,24 months,18,0.3114725731
Marketscan,TNF,Cardiac disease,Myocardial infarction,4797,5779,36 months,19,0.3287766049
Marketscan,TNF,Cardiac disease,Myocardial infarction,4797,5779,AS cohort entry to exposure,14,0.2422564458
Marketscan,TNF,Infection,Hospitalized infection,4797,5779,12 months,168,2.907077349
Marketscan,TNF,Infection,Hospitalized infection,4797,5779,24 months,247,4.2740958643
Marketscan,TNF,Infection,Hospitalized infection,4797,5779,36 months,277,4.7932168195
Marketscan,TNF,Infection,Hospitalized infection,4797,5779,AS cohort entry to exposure,144,2.4917805849
Marketscan,TNF,Infection,Opportunistic infection,4797,5779,12 months,43,0.7440733691
Marketscan,TNF,Infection,Opportunistic infection,4797,5779,24 months,53,0.9171136875
Marketscan,TNF,Infection,Opportunistic infection,4797,5779,36 months,55,0.9517217512
Marketscan,TNF,Infection,Opportunistic infection,4797,5779,AS cohort entry to exposure,36,0.6229451462
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,4797,5779,12 months,214,3.7030628136
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,4797,5779,24 months,256,4.4298321509
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,4797,5779,36 months,271,4.6893926285
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,4797,5779,AS cohort entry to exposure,166,2.8724692853
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,4797,5779,12 months,126,2.1803080118
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,4797,5779,24 months,146,2.5263886486
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,4797,5779,36 months,155,2.6821249351
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,4797,5779,AS cohort entry to exposure,89,1.5400588337
Marketscan,TNF,Kidney disease,Amyloidosis,4797,5779,12 months,0,0
Marketscan,TNF,Kidney disease,Amyloidosis,4797,5779,24 months,1,0.0173040318
Marketscan,TNF,Kidney disease,Amyloidosis,4797,5779,36 months,1,0.0173040318
Marketscan,TNF,Kidney disease,Amyloidosis,4797,5779,AS cohort entry to exposure,0,0
Marketscan,TNF,Kidney disease,IgA nephropathy,4797,5779,12 months,3,0.0519120955
Marketscan,TNF,Kidney disease,IgA nephropathy,4797,5779,24 months,3,0.0519120955
Marketscan,TNF,Kidney disease,IgA nephropathy,4797,5779,36 months,3,0.0519120955
Marketscan,TNF,Kidney disease,IgA nephropathy,4797,5779,AS cohort entry to exposure,0,0
Marketscan,TNF,Lung disease,Interstitial lung disease,4797,5779,12 months,4,0.0692161274
Marketscan,TNF,Lung disease,Interstitial lung disease,4797,5779,24 months,4,0.0692161274
Marketscan,TNF,Lung disease,Interstitial lung disease,4797,5779,36 months,4,0.0692161274
Marketscan,TNF,Lung disease,Interstitial lung disease,4797,5779,AS cohort entry to exposure,3,0.0519120955
Marketscan,TNF,Lung disease,Restrictive lung disease ,4797,5779,12 months,39,0.6748572417
Marketscan,TNF,Lung disease,Restrictive lung disease ,4797,5779,24 months,53,0.9171136875
Marketscan,TNF,Lung disease,Restrictive lung disease ,4797,5779,36 months,60,1.0382419104
Marketscan,TNF,Lung disease,Restrictive lung disease ,4797,5779,AS cohort entry to exposure,38,0.6575532099
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,4797,5779,12 months,0,0
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,4797,5779,24 months,0,0
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,4797,5779,36 months,1,0.0173040318
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,4797,5779,AS cohort entry to exposure,1,0.0173040318
Marketscan,TNF,Neurological Disease,Spinal Cord compression,4797,5779,12 months,5,0.0865201592
Marketscan,TNF,Neurological Disease,Spinal Cord compression,4797,5779,24 months,9,0.1557362866
Marketscan,TNF,Neurological Disease,Spinal Cord compression,4797,5779,36 months,11,0.1903443502
Marketscan,TNF,Neurological Disease,Spinal Cord compression,4797,5779,AS cohort entry to exposure,2,0.0346080637
Marketscan,TNF,PsO/PsA,Psoriasis,4797,5779,12 months,49,0.8478975601
Marketscan,TNF,PsO/PsA,Psoriasis,4797,5779,24 months,65,1.1247620696
Marketscan,TNF,PsO/PsA,Psoriasis,4797,5779,36 months,80,1.3843225472
Marketscan,TNF,PsO/PsA,Psoriasis,4797,5779,AS cohort entry to exposure,36,0.6229451462
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,4797,5779,12 months,129,2.2322201073
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,4797,5779,24 months,162,2.803253158
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,4797,5779,36 months,175,3.0282055719
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,4797,5779,AS cohort entry to exposure,110,1.9034435023
Marketscan,TNF,Uveitis,Uveitis,4797,5779,12 months,107,1.8515314068
Marketscan,TNF,Uveitis,Uveitis,4797,5779,24 months,122,2.1110918844
Marketscan,TNF,Uveitis,Uveitis,4797,5779,36 months,127,2.1976120436
Marketscan,TNF,Uveitis,Uveitis,4797,5779,AS cohort entry to exposure,65,1.1247620696
Medicare,DMARD,Cancer,Hematologic Cancer,4231,5193,12 months,105,2.0219526285
Medicare,DMARD,Cancer,Hematologic Cancer,4231,5193,24 months,139,2.6766801464
Medicare,DMARD,Cancer,Hematologic Cancer,4231,5193,36 months,159,3.0618139804
Medicare,DMARD,Cancer,Hematologic Cancer,4231,5193,AS cohort entry to exposure,101,1.9449258617
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,4231,5193,12 months,49,0.9435778933
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,4231,5193,24 months,91,1.7523589447
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,4231,5193,36 months,120,2.310803004
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,4231,5193,AS cohort entry to exposure,41,0.7895243597
Medicare,DMARD,Cancer,Solid Cancer,4231,5193,12 months,465,8.9543616407
Medicare,DMARD,Cancer,Solid Cancer,4231,5193,24 months,613,11.804352012
Medicare,DMARD,Cancer,Solid Cancer,4231,5193,36 months,703,13.537454265
Medicare,DMARD,Cancer,Solid Cancer,4231,5193,AS cohort entry to exposure,399,7.6834199884
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4231,5193,12 months,176,3.3891777393
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4231,5193,24 months,274,5.2763335259
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4231,5193,36 months,340,6.5472751781
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4231,5193,AS cohort entry to exposure,176,3.3891777393
Medicare,DMARD,Cardiac disease,Conduction Block,4231,5193,12 months,146,2.8114769883
Medicare,DMARD,Cardiac disease,Conduction Block,4231,5193,24 months,225,4.3327556326
Medicare,DMARD,Cardiac disease,Conduction Block,4231,5193,36 months,284,5.4689004429
Medicare,DMARD,Cardiac disease,Conduction Block,4231,5193,AS cohort entry to exposure,140,2.6959368381
Medicare,DMARD,Cardiac disease,Myocardial infarction,4231,5193,12 months,31,0.5969574427
Medicare,DMARD,Cardiac disease,Myocardial infarction,4231,5193,24 months,53,1.0206046601
Medicare,DMARD,Cardiac disease,Myocardial infarction,4231,5193,36 months,76,1.4635085692
Medicare,DMARD,Cardiac disease,Myocardial infarction,4231,5193,AS cohort entry to exposure,33,0.6354708261
Medicare,DMARD,Infection,Hospitalized infection,4231,5193,12 months,583,11.226651261
Medicare,DMARD,Infection,Hospitalized infection,4231,5193,24 months,862,16.599268246
Medicare,DMARD,Infection,Hospitalized infection,4231,5193,36 months,1069,20.585403428
Medicare,DMARD,Infection,Hospitalized infection,4231,5193,AS cohort entry to exposure,659,12.690159831
Medicare,DMARD,Infection,Opportunistic infection,4231,5193,12 months,163,3.1388407472
Medicare,DMARD,Infection,Opportunistic infection,4231,5193,24 months,225,4.3327556326
Medicare,DMARD,Infection,Opportunistic infection,4231,5193,36 months,266,5.1222799923
Medicare,DMARD,Infection,Opportunistic infection,4231,5193,AS cohort entry to exposure,173,3.3314076642
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,4231,5193,12 months,333,6.4124783362
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,4231,5193,24 months,370,7.1249759291
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,4231,5193,36 months,391,7.5293664548
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,4231,5193,AS cohort entry to exposure,327,6.296938186
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,4231,5193,12 months,198,3.8128249567
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,4231,5193,24 months,241,4.6408626998
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,4231,5193,36 months,272,5.2378201425
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,4231,5193,AS cohort entry to exposure,215,4.1401887156
Medicare,DMARD,Kidney disease,Amyloidosis,4231,5193,12 months,1,0.0192566917
Medicare,DMARD,Kidney disease,Amyloidosis,4231,5193,24 months,1,0.0192566917
Medicare,DMARD,Kidney disease,Amyloidosis,4231,5193,36 months,1,0.0192566917
Medicare,DMARD,Kidney disease,Amyloidosis,4231,5193,AS cohort entry to exposure,1,0.0192566917
Medicare,DMARD,Kidney disease,IgA nephropathy,4231,5193,12 months,13,0.2503369921
Medicare,DMARD,Kidney disease,IgA nephropathy,4231,5193,24 months,18,0.3466204506
Medicare,DMARD,Kidney disease,IgA nephropathy,4231,5193,36 months,19,0.3658771423
Medicare,DMARD,Kidney disease,IgA nephropathy,4231,5193,AS cohort entry to exposure,21,0.4043905257
Medicare,DMARD,Kidney disease,Nephrotic syndrome,4231,5193,12 months,13,0.2503369921
Medicare,DMARD,Kidney disease,Nephrotic syndrome,4231,5193,24 months,18,0.3466204506
Medicare,DMARD,Kidney disease,Nephrotic syndrome,4231,5193,36 months,19,0.3658771423
Medicare,DMARD,Kidney disease,Nephrotic syndrome,4231,5193,AS cohort entry to exposure,8,0.1540535336
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,4231,5193,12 months,3,0.0577700751
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,4231,5193,24 months,3,0.0577700751
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,4231,5193,36 months,3,0.0577700751
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,4231,5193,AS cohort entry to exposure,3,0.0577700751
Medicare,DMARD,Lung disease,Interstitial lung disease,4231,5193,12 months,15,0.2888503755
Medicare,DMARD,Lung disease,Interstitial lung disease,4231,5193,24 months,24,0.4621606008
Medicare,DMARD,Lung disease,Interstitial lung disease,4231,5193,36 months,29,0.5584440593
Medicare,DMARD,Lung disease,Interstitial lung disease,4231,5193,AS cohort entry to exposure,12,0.2310803004
Medicare,DMARD,Lung disease,Restrictive lung disease ,4231,5193,12 months,488,9.3972655498
Medicare,DMARD,Lung disease,Restrictive lung disease ,4231,5193,24 months,687,13.229347198
Medicare,DMARD,Lung disease,Restrictive lung disease ,4231,5193,36 months,837,16.117850953
Medicare,DMARD,Lung disease,Restrictive lung disease ,4231,5193,AS cohort entry to exposure,544,10.475640285
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,4231,5193,12 months,1,0.0192566917
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,4231,5193,24 months,3,0.0577700751
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,4231,5193,36 months,5,0.0962834585
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,4231,5193,AS cohort entry to exposure,12,0.2310803004
Medicare,DMARD,Neurological Disease,Spinal Cord compression,4231,5193,12 months,36,0.6932409012
Medicare,DMARD,Neurological Disease,Spinal Cord compression,4231,5193,24 months,56,1.0783747352
Medicare,DMARD,Neurological Disease,Spinal Cord compression,4231,5193,36 months,62,1.1939148854
Medicare,DMARD,Neurological Disease,Spinal Cord compression,4231,5193,AS cohort entry to exposure,49,0.9435778933
Medicare,DMARD,PsO/PsA,Psoriasis,4231,5193,12 months,182,3.5047178895
Medicare,DMARD,PsO/PsA,Psoriasis,4231,5193,24 months,233,4.4868091662
Medicare,DMARD,PsO/PsA,Psoriasis,4231,5193,36 months,263,5.0645099172
Medicare,DMARD,PsO/PsA,Psoriasis,4231,5193,AS cohort entry to exposure,170,3.2736375891
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,4231,5193,12 months,442,8.5114577316
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,4231,5193,24 months,511,9.8401694589
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,4231,5193,36 months,551,10.610437127
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,4231,5193,AS cohort entry to exposure,420,8.0878105142
Medicare,DMARD,Uveitis,Uveitis,4231,5193,12 months,276,5.3148469093
Medicare,DMARD,Uveitis,Uveitis,4231,5193,24 months,354,6.8168688619
Medicare,DMARD,Uveitis,Uveitis,4231,5193,36 months,395,7.6063932216
Medicare,DMARD,Uveitis,Uveitis,4231,5193,AS cohort entry to exposure,295,5.6807240516
Medicare,NSAID or no exposure,Cancer,Hematologic Cancer,17983,26122,12 months,543,2.0787076028
Medicare,NSAID or no exposure,Cancer,Hematologic Cancer,17983,26122,24 months,659,2.5227777352
Medicare,NSAID or no exposure,Cancer,Hematologic Cancer,17983,26122,36 months,734,2.809892045
Medicare,NSAID or no exposure,Cancer,Hematologic Cancer,17983,26122,AS cohort entry to exposure,308,1.1790827655
Medicare,NSAID or no exposure,Cancer,Non Melanoma Skin Cancer,17983,26122,12 months,393,1.5044789832
Medicare,NSAID or no exposure,Cancer,Non Melanoma Skin Cancer,17983,26122,24 months,626,2.3964474389
Medicare,NSAID or no exposure,Cancer,Non Melanoma Skin Cancer,17983,26122,36 months,779,2.9821606309
Medicare,NSAID or no exposure,Cancer,Non Melanoma Skin Cancer,17983,26122,AS cohort entry to exposure,172,0.6584488171
Medicare,NSAID or no exposure,Cancer,Solid Cancer,17983,26122,12 months,3160,12.097082919
Medicare,NSAID or no exposure,Cancer,Solid Cancer,17983,26122,24 months,3823,14.635173417
Medicare,NSAID or no exposure,Cancer,Solid Cancer,17983,26122,36 months,4205,16.097542302
Medicare,NSAID or no exposure,Cancer,Solid Cancer,17983,26122,AS cohort entry to exposure,1675,6.412219585
Medicare,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,17983,26122,12 months,1180,4.5172651405
Medicare,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,17983,26122,24 months,1586,6.0715106041
Medicare,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,17983,26122,36 months,1853,7.0936375469
Medicare,NSAID or no exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,17983,26122,AS cohort entry to exposure,628,2.4041038205
Medicare,NSAID or no exposure,Cardiac disease,Conduction Block,17983,26122,12 months,1184,4.5325779037
Medicare,NSAID or no exposure,Cardiac disease,Conduction Block,17983,26122,24 months,1710,6.5462062629
Medicare,NSAID or no exposure,Cardiac disease,Conduction Block,17983,26122,36 months,2031,7.7750555088
Medicare,NSAID or no exposure,Cardiac disease,Conduction Block,17983,26122,AS cohort entry to exposure,696,2.6644207947
Medicare,NSAID or no exposure,Cardiac disease,Myocardial infarction,17983,26122,12 months,268,1.0259551336
Medicare,NSAID or no exposure,Cardiac disease,Myocardial infarction,17983,26122,24 months,379,1.4508843121
Medicare,NSAID or no exposure,Cardiac disease,Myocardial infarction,17983,26122,36 months,461,1.7647959574
Medicare,NSAID or no exposure,Cardiac disease,Myocardial infarction,17983,26122,AS cohort entry to exposure,128,0.490008422
Medicare,NSAID or no exposure,Infection,Hospitalized infection,17983,26122,12 months,4024,15.404639767
Medicare,NSAID or no exposure,Infection,Hospitalized infection,17983,26122,24 months,5314,20.343005895
Medicare,NSAID or no exposure,Infection,Hospitalized infection,17983,26122,36 months,6081,23.279228237
Medicare,NSAID or no exposure,Infection,Hospitalized infection,17983,26122,AS cohort entry to exposure,2770,10.604088508
Medicare,NSAID or no exposure,Infection,Opportunistic infection,17983,26122,12 months,553,2.1169895108
Medicare,NSAID or no exposure,Infection,Opportunistic infection,17983,26122,24 months,804,3.0778654008
Medicare,NSAID or no exposure,Infection,Opportunistic infection,17983,26122,36 months,984,3.7669397443
Medicare,NSAID or no exposure,Infection,Opportunistic infection,17983,26122,AS cohort entry to exposure,399,1.527448128
Medicare,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,17983,26122,12 months,1054,4.0349131001
Medicare,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,17983,26122,24 months,1186,4.5402342853
Medicare,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,17983,26122,36 months,1267,4.8503177398
Medicare,NSAID or no exposure,Inflammatory bowel disease,Crohn’s Disease,17983,26122,AS cohort entry to exposure,683,2.6146543144
Medicare,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,17983,26122,12 months,597,2.2854299058
Medicare,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,17983,26122,24 months,778,2.9783324401
Medicare,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,17983,26122,36 months,889,3.4032616186
Medicare,NSAID or no exposure,Inflammatory bowel disease,Ulcerative Colitis,17983,26122,AS cohort entry to exposure,410,1.5695582268
Medicare,NSAID or no exposure,Kidney disease,Amyloidosis,17983,26122,12 months,23,0.0880483883
Medicare,NSAID or no exposure,Kidney disease,Amyloidosis,17983,26122,24 months,27,0.1033611515
Medicare,NSAID or no exposure,Kidney disease,Amyloidosis,17983,26122,36 months,33,0.1263302963
Medicare,NSAID or no exposure,Kidney disease,Amyloidosis,17983,26122,AS cohort entry to exposure,14,0.0535946712
Medicare,NSAID or no exposure,Kidney disease,IgA nephropathy,17983,26122,12 months,61,0.2335196386
Medicare,NSAID or no exposure,Kidney disease,IgA nephropathy,17983,26122,24 months,89,0.3407089809
Medicare,NSAID or no exposure,Kidney disease,IgA nephropathy,17983,26122,36 months,113,0.4325855601
Medicare,NSAID or no exposure,Kidney disease,IgA nephropathy,17983,26122,AS cohort entry to exposure,60,0.2296914478
Medicare,NSAID or no exposure,Kidney disease,Nephrotic syndrome,17983,26122,12 months,48,0.1837531583
Medicare,NSAID or no exposure,Kidney disease,Nephrotic syndrome,17983,26122,24 months,62,0.2373478294
Medicare,NSAID or no exposure,Kidney disease,Nephrotic syndrome,17983,26122,36 months,67,0.2564887834
Medicare,NSAID or no exposure,Kidney disease,Nephrotic syndrome,17983,26122,AS cohort entry to exposure,20,0.0765638159
Medicare,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,17983,26122,12 months,8,0.0306255264
Medicare,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,17983,26122,24 months,10,0.038281908
Medicare,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,17983,26122,36 months,11,0.0421100988
Medicare,NSAID or no exposure,Lung disease,Apical Pulmonary fibrosis,17983,26122,AS cohort entry to exposure,5,0.019140954
Medicare,NSAID or no exposure,Lung disease,Interstitial lung disease,17983,26122,12 months,18,0.0689074343
Medicare,NSAID or no exposure,Lung disease,Interstitial lung disease,17983,26122,24 months,27,0.1033611515
Medicare,NSAID or no exposure,Lung disease,Interstitial lung disease,17983,26122,36 months,37,0.1416430595
Medicare,NSAID or no exposure,Lung disease,Interstitial lung disease,17983,26122,AS cohort entry to exposure,17,0.0650792435
Medicare,NSAID or no exposure,Lung disease,Restrictive lung disease ,17983,26122,12 months,2525,9.6661817625
Medicare,NSAID or no exposure,Lung disease,Restrictive lung disease ,17983,26122,24 months,3564,13.643672001
Medicare,NSAID or no exposure,Lung disease,Restrictive lung disease ,17983,26122,36 months,4199,16.074573157
Medicare,NSAID or no exposure,Lung disease,Restrictive lung disease ,17983,26122,AS cohort entry to exposure,1609,6.1595589924
Medicare,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,17983,26122,12 months,51,0.1952377306
Medicare,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,17983,26122,24 months,63,0.2411760202
Medicare,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,17983,26122,36 months,66,0.2526605926
Medicare,NSAID or no exposure,Neurological Disease,Cauda Equina syndrome,17983,26122,AS cohort entry to exposure,33,0.1263302963
Medicare,NSAID or no exposure,Neurological Disease,Spinal Cord compression,17983,26122,12 months,319,1.2211928643
Medicare,NSAID or no exposure,Neurological Disease,Spinal Cord compression,17983,26122,24 months,391,1.4968226016
Medicare,NSAID or no exposure,Neurological Disease,Spinal Cord compression,17983,26122,36 months,434,1.6614348059
Medicare,NSAID or no exposure,Neurological Disease,Spinal Cord compression,17983,26122,AS cohort entry to exposure,185,0.7082152975
Medicare,NSAID or no exposure,PsO/PsA,Psoriasis,17983,26122,12 months,462,1.7686241482
Medicare,NSAID or no exposure,PsO/PsA,Psoriasis,17983,26122,24 months,631,2.4155883929
Medicare,NSAID or no exposure,PsO/PsA,Psoriasis,17983,26122,36 months,725,2.7754383278
Medicare,NSAID or no exposure,PsO/PsA,Psoriasis,17983,26122,AS cohort entry to exposure,354,1.3551795421
Medicare,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,17983,26122,12 months,833,3.1888829339
Medicare,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,17983,26122,24 months,991,3.7937370799
Medicare,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,17983,26122,36 months,1096,4.1956971135
Medicare,NSAID or no exposure,PsO/PsA,Psoriatic arthritis,17983,26122,AS cohort entry to exposure,718,2.7486409923
Medicare,NSAID or no exposure,Uveitis,Uveitis,17983,26122,12 months,1080,4.1344460608
Medicare,NSAID or no exposure,Uveitis,Uveitis,17983,26122,24 months,1391,5.3250133987
Medicare,NSAID or no exposure,Uveitis,Uveitis,17983,26122,36 months,1550,5.9336957354
Medicare,NSAID or no exposure,Uveitis,Uveitis,17983,26122,AS cohort entry to exposure,843,3.2271648419
Medicare,TNF,Cancer,Hematologic Cancer,4866,5929,12 months,47,0.7927137797
Medicare,TNF,Cancer,Hematologic Cancer,4866,5929,24 months,70,1.1806375443
Medicare,TNF,Cancer,Hematologic Cancer,4866,5929,36 months,93,1.5685613088
Medicare,TNF,Cancer,Hematologic Cancer,4866,5929,AS cohort entry to exposure,55,0.9276437848
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,4866,5929,12 months,56,0.9445100354
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,4866,5929,24 months,83,1.3998988025
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,4866,5929,36 months,111,1.8721538202
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,4866,5929,AS cohort entry to exposure,50,0.8433125316
Medicare,TNF,Cancer,Solid Cancer,4866,5929,12 months,392,6.6115702479
Medicare,TNF,Cancer,Solid Cancer,4866,5929,24 months,506,8.53432282
Medicare,TNF,Cancer,Solid Cancer,4866,5929,36 months,598,10.086017878
Medicare,TNF,Cancer,Solid Cancer,4866,5929,AS cohort entry to exposure,354,5.9706527239
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4866,5929,12 months,147,2.479338843
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4866,5929,24 months,232,3.9129701467
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4866,5929,36 months,283,4.773148929
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4866,5929,AS cohort entry to exposure,169,2.8503963569
Medicare,TNF,Cardiac disease,Conduction Block,4866,5929,12 months,128,2.158880081
Medicare,TNF,Cardiac disease,Conduction Block,4866,5929,24 months,217,3.6599763872
Medicare,TNF,Cardiac disease,Conduction Block,4866,5929,36 months,281,4.7394164277
Medicare,TNF,Cardiac disease,Conduction Block,4866,5929,AS cohort entry to exposure,157,2.6480013493
Medicare,TNF,Cardiac disease,Myocardial infarction,4866,5929,12 months,16,0.2698600101
Medicare,TNF,Cardiac disease,Myocardial infarction,4866,5929,24 months,35,0.5903187721
Medicare,TNF,Cardiac disease,Myocardial infarction,4866,5929,36 months,49,0.826446281
Medicare,TNF,Cardiac disease,Myocardial infarction,4866,5929,AS cohort entry to exposure,29,0.4891212683
Medicare,TNF,Infection,Hospitalized infection,4866,5929,12 months,426,7.1850227694
Medicare,TNF,Infection,Hospitalized infection,4866,5929,24 months,748,12.615955473
Medicare,TNF,Infection,Hospitalized infection,4866,5929,36 months,937,15.803676843
Medicare,TNF,Infection,Hospitalized infection,4866,5929,AS cohort entry to exposure,551,9.2933040985
Medicare,TNF,Infection,Opportunistic infection,4866,5929,12 months,196,3.305785124
Medicare,TNF,Infection,Opportunistic infection,4866,5929,24 months,277,4.6719514252
Medicare,TNF,Infection,Opportunistic infection,4866,5929,36 months,329,5.5489964581
Medicare,TNF,Infection,Opportunistic infection,4866,5929,AS cohort entry to exposure,230,3.8792376455
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,4866,5929,12 months,496,8.3656603137
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,4866,5929,24 months,540,9.1077753415
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,4866,5929,36 months,562,9.4788328555
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,4866,5929,AS cohort entry to exposure,467,7.8765390454
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,4866,5929,12 months,247,4.1659639062
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,4866,5929,24 months,311,5.2454039467
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,4866,5929,36 months,347,5.8525889695
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,4866,5929,AS cohort entry to exposure,266,4.4864226682
Medicare,TNF,Kidney disease,Amyloidosis,4866,5929,12 months,6,0.1011975038
Medicare,TNF,Kidney disease,Amyloidosis,4866,5929,24 months,11,0.185528757
Medicare,TNF,Kidney disease,Amyloidosis,4866,5929,36 months,11,0.185528757
Medicare,TNF,Kidney disease,Amyloidosis,4866,5929,AS cohort entry to exposure,6,0.1011975038
Medicare,TNF,Kidney disease,IgA nephropathy,4866,5929,12 months,11,0.185528757
Medicare,TNF,Kidney disease,IgA nephropathy,4866,5929,24 months,23,0.3879237645
Medicare,TNF,Kidney disease,IgA nephropathy,4866,5929,36 months,28,0.4722550177
Medicare,TNF,Kidney disease,IgA nephropathy,4866,5929,AS cohort entry to exposure,15,0.2529937595
Medicare,TNF,Kidney disease,Nephrotic syndrome,4866,5929,12 months,11,0.185528757
Medicare,TNF,Kidney disease,Nephrotic syndrome,4866,5929,24 months,21,0.3541912633
Medicare,TNF,Kidney disease,Nephrotic syndrome,4866,5929,36 months,26,0.4385225164
Medicare,TNF,Kidney disease,Nephrotic syndrome,4866,5929,AS cohort entry to exposure,7,0.1180637544
Medicare,TNF,Lung disease,Apical Pulmonary fibrosis,4866,5929,12 months,0,0
Medicare,TNF,Lung disease,Apical Pulmonary fibrosis,4866,5929,24 months,0,0
Medicare,TNF,Lung disease,Apical Pulmonary fibrosis,4866,5929,36 months,0,0
Medicare,TNF,Lung disease,Apical Pulmonary fibrosis,4866,5929,AS cohort entry to exposure,1,0.0168662506
Medicare,TNF,Lung disease,Interstitial lung disease,4866,5929,12 months,4,0.0674650025
Medicare,TNF,Lung disease,Interstitial lung disease,4866,5929,24 months,10,0.1686625063
Medicare,TNF,Lung disease,Interstitial lung disease,4866,5929,36 months,13,0.2192612582
Medicare,TNF,Lung disease,Interstitial lung disease,4866,5929,AS cohort entry to exposure,11,0.185528757
Medicare,TNF,Lung disease,Restrictive lung disease ,4866,5929,12 months,388,6.5441052454
Medicare,TNF,Lung disease,Restrictive lung disease ,4866,5929,24 months,620,10.457075392
Medicare,TNF,Lung disease,Restrictive lung disease ,4866,5929,36 months,760,12.818350481
Medicare,TNF,Lung disease,Restrictive lung disease ,4866,5929,AS cohort entry to exposure,474,7.9946027998
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,4866,5929,12 months,8,0.1349300051
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,4866,5929,24 months,14,0.2361275089
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,4866,5929,36 months,15,0.2529937595
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,4866,5929,AS cohort entry to exposure,6,0.1011975038
Medicare,TNF,Neurological Disease,Spinal Cord compression,4866,5929,12 months,30,0.505987519
Medicare,TNF,Neurological Disease,Spinal Cord compression,4866,5929,24 months,46,0.7758475291
Medicare,TNF,Neurological Disease,Spinal Cord compression,4866,5929,36 months,61,1.0288412886
Medicare,TNF,Neurological Disease,Spinal Cord compression,4866,5929,AS cohort entry to exposure,48,0.8095800304
Medicare,TNF,PsO/PsA,Psoriasis,4866,5929,12 months,299,5.0430089391
Medicare,TNF,PsO/PsA,Psoriasis,4866,5929,24 months,379,6.3923089897
Medicare,TNF,PsO/PsA,Psoriasis,4866,5929,36 months,418,7.0500927644
Medicare,TNF,PsO/PsA,Psoriasis,4866,5929,AS cohort entry to exposure,289,4.8743464328
Medicare,TNF,PsO/PsA,Psoriatic arthritis,4866,5929,12 months,650,10.963062911
Medicare,TNF,PsO/PsA,Psoriatic arthritis,4866,5929,24 months,748,12.615955473
Medicare,TNF,PsO/PsA,Psoriatic arthritis,4866,5929,36 months,805,13.577331759
Medicare,TNF,PsO/PsA,Psoriatic arthritis,4866,5929,AS cohort entry to exposure,645,10.878731658
Medicare,TNF,Uveitis,Uveitis,4866,5929,12 months,473,7.9777365492
Medicare,TNF,Uveitis,Uveitis,4866,5929,24 months,587,9.9004891213
Medicare,TNF,Uveitis,Uveitis,4866,5929,36 months,655,11.047394164
Medicare,TNF,Uveitis,Uveitis,4866,5929,AS cohort entry to exposure,504,8.5005903188
